Literature DB >> 9814064

[Definition and epidemiology of vascular acrosyndromes].

P H Carpentier1.   

Abstract

Vascular acrosyndromes group several disorders around Raynaud's phenomenon, characterized by a distal involvement and a vasomotor pathogenesis. Their exact mechanisms remain unknown, but epidemiological data favour disturbances of thermoregulation: cold climate, outdoor occupation and low body mass index are significant risk factors for most of them. Acrosyndromes with vasoconstriction are highly prevalent in France: 10 to 15% for Raynaud's phenomenon and acrocyanosis; 2 to 6% for chilblains. Acrosyndromes with vasodilatation (acrocholose, erythermalgia) are much rare. There is no link between Raynaud's phenomenon and tobacco use, alcohol consumption, oestrogen treatment, carpal tunnel syndrome or thoracic outlet syndrome. By contrast, the role of connective tissue diseases and occupational disorders (vibration exposure and hand-hammer syndrome) are established.

Entities:  

Mesh:

Year:  1998        PMID: 9814064

Source DB:  PubMed          Journal:  Rev Prat        ISSN: 0035-2640


  5 in total

1.  [Capillaroscopy. Procedure and nomenclature].

Authors:  O Sander; C Sunderkötter; I Kötter; I Wagner; M Becker; I Herrgott; A Schwarting; B Ostendorf; C Iking-Konert; E Genth
Journal:  Z Rheumatol       Date:  2010-05       Impact factor: 1.372

2.  Pernio (chilblains).

Authors:  Amjad Almahameed; Duane S Pinto
Journal:  Curr Treat Options Cardiovasc Med       Date:  2008-04

3.  Pattern of chilblains in a high altitude region of Ladakh, India.

Authors:  G K Singh; A Datta; R S Grewal; M S Suresh; S S Vaishampayan
Journal:  Med J Armed Forces India       Date:  2013-05-10

Review 4.  The position of geochemical variables as causal co-factors of diseases of unknown aetiology.

Authors:  Theophilus C Davies
Journal:  SN Appl Sci       Date:  2022-07-27

5.  Acrocyanosis: an overview.

Authors:  Sudip Das; Arunasis Maiti
Journal:  Indian J Dermatol       Date:  2013-11       Impact factor: 1.494

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.